In vivo targeting of leukemia stem cells by directing parthenolide-loaded nanoparticles to the bone marrow niche

Bone marrow endothelium-targeted therapeutics for metastatic breast cancer

(2014) Junhua Mai et al.   JOURNAL OF CONTROLLED RELEASE

Selective Activity of the Histone Deacetylase Inhibitor AR-42 against Leukemia Stem Cells: A Novel Potential Strategy in Acute Myelogenous Leukemia

(2014) M. L. Guzman et al.   MOLECULAR CANCER THERAPEUTICS

Concise Review: Leukemia Stem Cells in Personalized Medicine

(2013) Monica L. Guzman et al.   STEM CELLS

E-Selectin-Targeted Porous Silicon Particle for Nanoparticle Delivery to the Bone Marrow

(2011) Aman P. Mann et al.   ADVANCED MATERIALS

Leukemia Stem Cells and Microenvironment: Biology and Therapeutic Targeting

(2011) Marina Y. Konopleva et al.   JOURNAL OF CLINICAL ONCOLOGY

Chemical genomic screening reveals synergism between parthenolide and inhibitors of the PI-3 kinase and mTOR pathways

(2010) D. C. Hassane et al.   BLOOD

Identification of Thioaptamer Ligand against E-Selectin: Potential Application for Inflamed Vasculature Targeting

(2010) Aman P. Mann et al.   PLoS One

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

(2009) H. Dohner et al.   BLOOD